Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page footer revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-21T01:34:49.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-23T03:12:13.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed, indicating a software version update with no changes to the study details.
    Difference
    0.0%
    Check dated 2026-03-08T23:41:36.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The change is a revision update from v3.4.1 to v3.4.2 with no impact on study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T15:02:27.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Peking University People's Hospital was added as a study site in early 2026 after a prior removal in December 2025; the page revision also updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-08T11:25:47.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Adds a glossary toggle and makes small text/capitalization changes to metadata fields (e.g., Last Update statuses and No FEAR Act data). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-25T03:46:12.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.